Colon News and Research

RSS

Great breakthrough in cancer diagnostics

An amazingly sensitive method for selective analysis of amino acids, sugars, fatty acids, and other vital compounds has been developed by Russian scientists.

16 Oct 2004

Genetic discovery may hold clues to the development of many cases of the most common cancers

In a study published in Nature Genetics today, a team of scientists at The Institute of Cancer Research have discovered a gene that may hold clues to the development of many cases of the most common cancers including lung, breast, prostate and colon cancers.

12 Oct 2004

New research suggests that cancer cells can be reformed

New research by Dean Felsher, MD, PhD, assistant professor of medicine (oncology) and of pathology at the Stanford University School of Medicine, suggests that cancer cells can be reformed.

12 Oct 2004

New statement published on nonmalignant diseases related to asbestos exposure

In its first official statement since 1986 on the topic, the American Thoracic Society (ATS) has published a document entitled “Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos.”

4 Oct 2004

Novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread

By studying cancer in mice, researchers at The University of Texas at Austin have gained preliminary evidence that a novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread to other body sites.

30 Sep 2004

Even health conscious Americans report low rates of endoscopic screening for colorectal cancer

The study found just over half (54 percent) of men and women reported having ever undergone endoscopy (sigmoidoscopy or colonoscopy). The percentage that underwent either procedure in the past five years for screening rather than for disease diagnosis or follow up was just 24 percent.

30 Sep 2004

New anti-inflammatory strategy for cancer therapy

A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system’s inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.

20 Sep 2004

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

New oral gel used instead of injection to deliver drugs

Scientists in India have developed a new gel that is taken orally and is capable of delivering drugs to manage diseases often requiring an injection.

20 Sep 2004

Cancer survivors' other medical problems poorly managed

People who survive cancer are less likely to receive necessary care for a wide range of other non-cancer-related medical problems according to a new study published September 13, 2004 in the online edition of CANCER, a peer- reviewed journal of the American Cancer Society.

12 Sep 2004

Gene mutations cause 85 percent of colon cancers

Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.

9 Sep 2004

Cancers, including colon, prostate, and leukemia, continue to grow unchecked

Many cancers, including colon, prostate, and leukemia, continue to grow unchecked because they do not respond to a signal to die and stop proliferating from Transforming Growth Factor-beta (TGF-b).

8 Sep 2004

Men's magazines don’t inform men about prostate and colon cancer screening

Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men’s magazines.

8 Sep 2004

CT scans may be delivering as much radiation as a low-dose atomic bomb

Those full-body CT scans advertised at some health care centers may be delivering as much radiation as a low-dose atomic bomb, according to a new study. And that means people who get them could be raising their cancer risk, researchers from Columbia University report in the journal Radiology (Vol. 232, No. 3:735-738).

5 Sep 2004

Research provides definitive evidence that radiation risk is associated with full-body CT scans

The risk of cancer mortality from a single full-body computed tomography (CT) scan is modest, but not negligible, and the risks resulting from elective annual scans are much higher, according to a study published in the September issue of the journal Radiology.

31 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

New database about a group of genes associated with multidrug resistance in cancerous tumors

Scientists at the National Cancer Institute, have created a database of information about a group of genes associated with multidrug resistance in cancerous tumors.

23 Aug 2004

Effect of prebiotic and probiotic foods on health

A group of researchers at the Public University of Navarre, led by Senior Lecturer in Zoology, Elena Urdaneta Artola, have studied both the mechanisms whereby foodstuffs known as functional act at a gastrointestinal level as well as their possible beneficial effects on the health of individuals.

23 Aug 2004

60 percent of people with Crohn's disease have required surgery within the past five years

According to results released today from the newest survey of people with Crohn's disease, "Voices of Crohn's," 60 percent of people with Crohn's, between the ages of 18 and 34, have been hospitalized within the last two years and more than half have required surgery within the past five years.

18 Aug 2004

New colon cancer guidelines

The American Society of Clinical Oncology has developed a set of recommendations to address whether patients who have had successful surgery for Stage II colon cancer should be offered adjuvant chemotherapy in routine clinical practice.

17 Aug 2004